AVALO THERAPEUTICS INC AVTX

US Healthcare Pharmaceutical Preparations
$18.84
+9.0%
52w: $4.64 – $22.87

Latest 13F among current holders filed 31 days ago (Jun 4, 2026)

Price — last 12 months

research preview data
4.6413.7622.87
Jun 20, 2025 Jul 2, 2026
Institutional holders
97
+13 QoQ
13F value
$471.6M
+30.6% QoQ
Smart-money holders
25
signal tier ≥ 2
New smart buyers
8
Q1 2026
Options barometer
7.5×
$43.0M calls / $5.7M puts

Institutional value by quarter

$37.5M
Q1 2024
$9.6M
Q2 2024
$63.2M
Q3 2024
$56.0M
Q4 2024
$66.1M
Q1 2025
$39.1M
Q2 2025
$194.7M
Q3 2025
$361.1M
Q4 2025
$471.6M
Q1 2026

Number of holders

19
Q1 2024
22
Q2 2024
30
Q3 2024
34
Q4 2024
35
Q1 2025
37
Q2 2025
66
Q3 2025
84
Q4 2025
97
Q1 2026

Who owns AVTX?

Q1 2026 filings
FundTypeSharesValue% of fundChange
FMR LLC Long only active2.9M$43.0M0.0%+1207.1%
T. Rowe Price Investment Management, Inc. Long only active2.2M$32.3M0.0%New
Caligan Partners LP ★3Fundamental concentrated1.6M$24.4M1.7%+85.5%
BVF INC/IL ★3Fundamental concentrated1.6M$24.4M0.8%+20.5%
Avoro Capital Advisors LLC ★3Fundamental concentrated1.4M$21.1M0.2%New
Affinity Asset Advisors, LLC ★2Fundamental diversified1.3M$20.0M1.2%+27.6%
Nantahala Capital Management, LLC ★2Fundamental diversified1.2M$18.4M1.2%Held
UBS Group AG Bank broker1.1M$17.0M0.0%+139.0%
Point72 Asset Management, L.P. Multistrat pod916.1K$13.7M0.0%+46.0%
FARALLON CAPITAL MANAGEMENT LLC ★2Fundamental diversified916.0K$13.7M0.1%New
RTW INVESTMENTS, LP ★2Fundamental diversified857.0K$12.8M0.1%New
ADAGE CAPITAL PARTNERS GP, L.L.C. Other854.0K$12.8M0.0%+55.3%
MILLENNIUM MANAGEMENT LLC Multistrat pod835.5K$12.5M0.0%+26.6%
TCG Crossover Management, LLC ★3Fundamental concentrated738.4K$11.0M0.3%+52.9%
Balyasny Asset Management L.P. Multistrat pod731.6K$10.9M0.0%+66.5%
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical719.7K$10.7M0.0%
RA CAPITAL MANAGEMENT, L.P. ★2Fundamental diversified663.0K$9.9M0.1%Held
BANK OF AMERICA CORP /DE/ Bank broker643.0K$9.6M0.0%+3.5%
Commodore Capital LP ★3Fundamental concentrated483.0K$7.2M0.4%Held
ORBIMED ADVISORS LLC ★2Fundamental diversified475.2K$7.1M0.2%-60.0%
JENNISON ASSOCIATES LLC Other470.8K$7.0M0.0%-1.0%
Caption Management, LLC Quant stat arb455.0K$6.8M0.3%+764.3%
Soleus Capital Management, L.P. ★2Fundamental diversified442.0K$6.6M0.3%Held
BNP PARIBAS FINANCIAL MARKETS Bank broker422.8K$6.3M0.0%+113.8%
KENNEDY CAPITAL MANAGEMENT LLC Other388.0K$5.8M0.1%New
DV Trading LLC Wealth advisor360.1K$5.4M0.5%New
Seven Fleet Capital Management LP Quant stat arb360.1K$5.4M1.7%New
BlackRock, Inc. Index provider327.1K$4.9M0.0%+13.0%
BOOTHBAY FUND MANAGEMENT, LLC Diversified mechanical324.3K$4.8M0.1%+60.4%
Logos Global Management LP ★2Fundamental concentrated300.0K$4.5M0.2%New
Boxer Capital Management, LLC ★2Fundamental concentrated300.0K$4.5M0.6%+9.1%
Pivotal bioVenture Partners Investment Advisor LLC ★3Fundamental concentrated295.9K$4.4M1.6%New
STEMPOINT CAPITAL LP ★2Fundamental concentrated269.5K$4.0M0.4%+98.8%
Seven Fleet Capital Management LP Quant stat arb213.8K$3.2M1.0%+237.6%
CITADEL ADVISORS LLC Multistrat pod193.7K$2.9M0.0%-53.8%
NAN FUNG TRINITY (HK) LTD ★2Fundamental concentrated189.0K$2.8M0.3%Held
Velan Capital Investment Management LP ★2Fundamental concentrated185.1K$2.8M1.7%-29.8%
JPMORGAN CHASE & CO Bank broker194.4K$2.7M0.0%+337.5%
Qube Research & Technologies Ltd Quant stat arb174.5K$2.6M0.0%+170.7%
JANE STREET GROUP, LLC Market maker173.3K$2.6M0.0%-3.1%
AMERIPRISE FINANCIAL INC Bank broker172.1K$2.6M0.0%-21.0%
Aberdeen Group plc Other171.7K$2.6M0.0%+79.9%
GEODE CAPITAL MANAGEMENT, LLC Index provider169.9K$2.5M0.0%+2.2%
MORGAN STANLEY Bank broker161.4K$2.4M0.0%-39.1%
Hudson Bay Capital Management LP Multistrat pod161.1K$2.4M0.0%+860.5%
Exome Asset Management LLC ★2Fundamental diversified159.3K$2.4M1.4%New
Moody Aldrich Partners LLC Other159.3K$2.4M0.4%+19.6%
DEUTSCHE BANK AG\ Bank broker150.0K$2.2M0.0%Held
PERCEPTIVE ADVISORS LLC ★2Fundamental diversified139.7K$2.1M0.0%Held
MARSHALL WACE, LLP Quant stat arb129.1K$1.9M0.0%-74.6%

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.